LPS induces permeability injury in lung microvascular endothelium via AT1 receptor

Lipopolysaccharide (LPS) is known to stimulate the circulation and local production of angiotensin II (Ang II). To assess whether Ang II plays a role in LPS-induced acute lung injury, rats were injected with LPS, the microvascular endothelial permeability injury was evaluated by histological changes, increased pulmonary wet/dry weight ratio, and pulmonary microvascular protein leak. Besides, increased rat pulmonary microvascular endothelial cell monolayer permeability coefficient (Kf) was measured after treatment with LPS and/or Ang II, respectively. LPS/Ang II, treatment resulted in a significant increase in Kf. Ang II cooperates with LPS to further increase Kf. Hence, LPS increases pulmonary microvascular endothelial permeability both in vitro and in vivo. Local lung Ang II was increased in response to LPS challenge, and elevated Ang II ulteriorly exacerbates LPS-induced endothelium injury. [Sar1,Ile8]Ang II, a selective block of Ang II type 1 (AT1) receptors, eliminated these changes significantly. Our conclusion is that the LPS-induced lung injury may be mediated by the AT1 receptor.